Literature DB >> 2427749

An immunodominant domain in adenovirus type 2 early region 1A proteins.

A S Tsukamoto, B Ferguson, M Rosenberg, I L Weissman, A J Berk.   

Abstract

Six independent rat hybridoma cell lines producing monoclonal antibodies to human subgroup C adenovirus early region 1A (E1A) proteins were isolated. Competition binding experiments revealed that each of the monoclonal antibodies was directed against the same epitope or overlapping cluster of epitopes on the E1A proteins. Viral E1A deletion mutants and deleted forms of E1A proteins expressed in Escherichia coli were used to localize the antibody recognition sites to sequences between amino acids 23 and 120, encoded within the first exon of the E1A gene. Similarly, polyclonal antisera raised against the trpE-E1A fusion protein, as well as against the native, biologically active E1A protein, were also directed primarily against this immunodominant region.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427749      PMCID: PMC253933     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Transcriptional activation of cloned human beta-globin genes by viral immediate-early gene products.

Authors:  M R Green; R Treisman; T Maniatis
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

2.  Transcriptional activation and subsequent control of the human heat shock gene during adenovirus infection.

Authors:  H T Kao; J R Nevins
Journal:  Mol Cell Biol       Date:  1983-11       Impact factor: 4.272

3.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

4.  Complete transformation by adenovirus 2 requires both E1A proteins.

Authors:  C Montell; G Courtois; C Eng; A Berk
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

5.  Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.

Authors:  K R Spindler; D S Rosser; A J Berk
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

6.  Adenovirus early region 1A protein activates transcription of a nonviral gene introduced into mammalian cells by infection or transfection.

Authors:  R B Gaynor; D Hillman; A J Berk
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

7.  Identification of human adenovirus early region 1 products by using antisera against synthetic peptides corresponding to the predicted carboxy termini.

Authors:  S P Yee; D T Rowe; M L Tremblay; M McDermott; P E Branton
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

8.  The role of adenovirus early region 1A in the regulation of early regions 2A and 1B expression.

Authors:  M Rossini
Journal:  Virology       Date:  1983-11       Impact factor: 3.616

9.  Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells.

Authors:  P I Schrier; R Bernards; R T Vaessen; A Houweling; A J van der Eb
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

10.  Adenovirus stimulation of transcription by RNA polymerase III: evidence for an E1A-dependent increase in transcription factor IIIC concentration.

Authors:  S Yoshinaga; N Dean; M Han; A J Berk
Journal:  EMBO J       Date:  1986-02       Impact factor: 11.598

View more
  3 in total

1.  A protein kinase is present in a complex with adenovirus E1A proteins.

Authors:  T Kleinberger; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

2.  Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5.

Authors:  C Egan; T N Jelsma; J A Howe; S T Bayley; B Ferguson; P E Branton
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

Review 3.  Mapping of viral epitopes with prokaryotic expression products.

Authors:  J A Lenstra; J G Kusters; B A van der Zeijst
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.